Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Precigen (NASDAQ:PGEN)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Precigen Charts.

Precigen (NASDAQ:PGEN)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Precigen Charts.

Precigen Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 19 April 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 19 April 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 19 April 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 19 April 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 19 April 2025 (1 week ago) • Edgar (US Regulatory)

Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th
Wednesday 16 April 2025 (2 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 20 March 2025 (1 month ago) • Edgar (US Regulatory)

Precigen Reports Full Year 2024 Financial Results and Business Updates
Thursday 20 March 2025 (1 month ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 March 2025 (1 month ago) • Edgar (US Regulatory)

Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th
Thursday 13 March 2025 (1 month ago) • PR Newswire (US)

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025
Wednesday 26 February 2025 (2 months ago) • PR Newswire (US)

More Precigen Inc News Articles

Commonwealth Bank Of Aus...

Sterling vs AUD

Australia And New Zealan...

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions